Methods: A MEDLINE/EMBASE/CENTRAL search for randomized clinical trials published on this topic from 1966 to February 2012 was performed. Efficacy outcomes of decrease in systolic (SBP) and diastolic (DBP) blood pressures from baseline, changes in heart rate (HR), and adverse effects were compared between dual CCB therapy vs. DHP or NDHP. SBP, DBP, and HR were expressed as weighted mean deviation (WMD).
Results: A total of 6 studies with 153 patients were included. Dual CCB produced a significantly greater reduction in SBP (21.69.2 mmHg) from baseline than DHP (10.36.3 mmHg (WMD = 10.9 mmHg, P
max plus ii baseline version 10.2 26
Antitumor activity of alpelisib plus nab-paclitaxel based on RECIST v1.1. A, Best percentage change from baseline in the sum of longest diameters of target lesions. B, Longitudinal change from baseline in the sum of longest diameters of target lesions. C, Durability of response. A and B include patients who received at least one cycle of alpelisib and had available at least one postbaseline tumor assessment (n = 39). C includes all patients evaluable for response (N = 42).
It has been shown that hyperglycemia induced by PI3K inhibition leads to an increase in insulin levels, and this glucose-insulin feedback can reactivate PI3K signaling in mouse models even in the presence of PI3Ki (21). Dietary/pharmacologic measures (e.g., ketogenic diet and sodium-glucose cotransporter inhibitors) can diminish this insulin feedback, thus increasing treatment efficacy of PI3Ki (21). Patients with normal metabolic status in our study experienced longer PFS compared with prediabetic/diabetic patients. This effect was remarkably pronounced in the PIK3CA-mutated subgroup. It is plausible that baseline insulin resistance in prediabetic/diabetic patients may have played a role in decreasing the efficacy of the alpelisib. A somewhat similar observation was made in the international SANDPIPER trial, where differences in taselisib efficacy were observed according to geographic distribution (lesser efficacy in patients enrolled in Latin America/Eastern Europe compared with other parts of the world; ref. 15). Possible differences in degree of insulin resistance, diet, and perhaps hyperglycemia management in patients from different geographic regions may have contributed to these findings. These observations highlight the potential role of insulin resistance and glucose-insulin feedback on optimizing clinical efficacy of PI3Kis. The impact of metabolic status/insulin resistance and diet on effectiveness of PI3Kis should be evaluated further in ongoing studies.
A13 Bionic processor
10.2-inch display
$329 starting price tag ($299 for schools)
64 and 256GB capacities
Apple Pencil support
12-megapixel Ultra Wide front camera with Center Stage
8-megapixel rear camera
Touch ID
As with the seventh- and eighth-generation iPad, the ninth-generation iPad offers a 10.2-inch display, which offers more viewing area than the 9.7-inch iPad that was sold a few years prior. The 10.2-inch iPad is Apple's smallest iPad display after the 8.3-inch iPad mini. The 10.2-inch display has a resolution of 2160 x 1620 at 264 pixels per inch and it offers nearly 3.5 million pixels along with 500 nits brightness.
Other iPad features include an 8-megapixel camera with 1080p video recording, Gigabit-class LTE for cellular models, an "all-day" 10 hours of battery life, Touch ID, Apple Pay support, and 802.11ac WiFi. First-generation Apple Pencil support is included, and there's a Smart Connector so the iPad works with the Smart Keyboard Folio for the 10.2-inch iPad.
Solved Problem 10.2: Assumethat the outside air temperature is 8C. If the air in a room is at25C with a relative humidity φ = 40%, use the psychrometric chartto determine if the windows of that room which are in contact withthe outside will become foggy. 2ff7e9595c
Comments